Table 1 Demographic characteristics of the EUropean patient survey in Atrial Fibrillation respondents*
From: Patient perspective on the management of atrial fibrillation in five European countries
France (N = 300) | Germany (N = 300) | Italy (N = 302) | Spain (N = 305) | UK (N = 300) | Total (N = 1507) | |
|---|---|---|---|---|---|---|
Mean age, years (SD) | 68.5 (13.7) | 70.4 (10.5) | 70.8 (12.2) | 70.8 (13.7) | 70.3 (11.9) | 70.1 (12.5) |
<50 years, n (%) | 22 (7.3) | 17 (5.7) | 19 (6.3) | 24 (7.9) | 20 (6.7) | 102 (6.8) |
50– < 65 years, n (%) | 91 (30.3) | 55 (18.3) | 57 (18.9) | 54 (17.7) | 65 (21.7) | 322 (21.4) |
≥65 years, n (%) | 187 (62.3) | 228 (76.0) | 226 (74.8) | 227 (74.4) | 215 (71.7) | 1083 (71.9) |
Male, n (%) | 153 (51.0) | 154 (51.3) | 152 (50.3) | 138 (45.2) | 153 (51.0) | 750 (49.8) |
Receiving oral anticoagulation n (%) ** | ||||||
Yes | 215 (71.7) | 232 (77.3) | 224 (74.2) | 253 (83.0) | 231 (77.0) | 1155 (76.6) |
No | 54 (18.0) | 37 (12.3) | 36 (11.9) | 24 (7.9) | 36 (12.0) | 187 (12.4) |
No response | 6 (2.0) | 2 (0.7) | 13 (4.3) | 5 (1.6) | 4 (1.3) | 30 (2.0) |
Not asked | 25 (8.3) | 29 (9.7) | 29 (9.6) | 23 (7.5) | 29 (9.7) | 135 (9.0) |
Income, n (%) | ||||||
Below average | 156 (52.0) | 175 (58.3) | 169 (56.0) | 196 (64.3) | 154 (51.3) | 850 (56.4) |
Average | 65 (21.7) | 37 (12.3) | 90 (29.8) | 42 (13.8) | 59 (19.7) | 293 (19.4) |
Above average | 50 (16.7) | 53 (17.7) | 16 (5.3) | 23 (7.5) | 57 (19.0) | 199 (13.2) |
No response | 29 (9.7) | 35 (11.7) | 27 (8.9) | 34 (14.4) | 30 (10.0) | 165 (10.9) |
CHADS 2 score, n (%) | ||||||
0 | 10 (3.3) | 9 (3.0) | 10 (3.3) | 10 (3.3) | 6 (2.0) | 45 (3.0) |
1–2 | 74 (24.7) | 83 (27.7) | 68 (22.5) | 70 (23.0) | 82 (27.3) | 377 (25.0) |
>2 | 216 (72.0) | 208 (69.3) | 224 (74.2) | 225 (73.8) | 212 (70.7) | 1085 (72.0) |
Number of current medications | ||||||
Mean (SD) | 5.7 (4.1) | 5.4 (4.0) | 5.4 (3.3) | 6.0 (3.9) | 6.1 (4.1) | 5.7 (3.9) |
>10 medications, n (%) | 46 (15.3) | 26 (8.7) | 34 (11.3) | 45 (14.8) | 48 (16.0) | 199 (13.2) |
Where respondents live, n (%) | ||||||
City/large town | 99 (33.0) | 76 (25.3) | 45 (14.9) | 138 (45.2) | 105 (35.0) | 463 (30.7) |
Small town | 87 (29.0) | 92 (30.7) | 90 (29.8) | 28 (9.2) | 89 (29.7) | 386 (25.6) |
Village/rural location | 113 (37.7) | 130 (43.3) | 165 (54.6) | 138 (45.2) | 105 (35.0) | 651 (43.2) |
No response | 1 (0.33) | 2 (0.67) | 2 (0.66) | 1 (0.33) | 1 (0.33) | 7 (0.46) |
Comorbidities, n (%) | ||||||
Mean | 2.1 | 2.1 | 2.2 | 2.3 | 2.3 | 2.2 |
Hypertension | 152 (50.7) | 208 (69.3) | 197 (65.2) | 180 (59.0) | 185 (61.7) | 922 (61.2) |
Heart disease | 165 (55.0) | 167 (55.7) | 130 (43.0) | 141 (46.2) | 135 (45.0) | 738 (49.0) |
Diabetes | 60 (20.0) | 78 (26.0) | 60 (19.9) | 68 (22.3) | 50 (16.7) | 316 (21.0) |
Arthritis | 69 (23.0) | 47 (15.7) | 127 (42.1) | 103 (33.8) | 144 (48.0) | 490 (32.5) |
Asthma, COPD, or other chronic lung disease | 55 (18.3) | 53 (17.7) | 48 (15.9) | 63 (20.7) | 49 (16.3) | 268 (17.8) |
Depression, anxiety, or other mental health problem | 90 (30.0) | 47 (15.7) | 75 (24.8) | 126 (41.3) | 77 (25.7) | 415 (27.5) |
Cancer | 39 (13.0) | 43 (14.3) | 31 (10.3) | 34 (11.1) | 40 (13.3) | 187 (12.4) |
Stroke | 78 (26.0) | 31 (10.3) | 59 (19.5) | 63 (20.7) | 95 (31.7) | 326 (21.6) |